Tetra Bio-Pharma Cancels $10 Million ATM Financing
It appears that Tetra Bio-Pharma (TSX: TBP) has cold feet when it comes to raising money. The company last night
Read moreIt appears that Tetra Bio-Pharma (TSX: TBP) has cold feet when it comes to raising money. The company last night
Read moreTetra Bio-Pharma Inc (TSXV: TBP) has issued an update regarding the working conditions for its employees, as well as the
Read moreTetra Bio Pharma (TSXV: TBP) has strengthened its product pipeline as of this morning, providing the company with new potential
Read moreTetra Bio Pharma (TSXV: TBP) announced further details surrounding its FDA clinical traisl of Qixleef this morning, including the expansion
Read moreTetra Bio Pharma (TSXV: TBP) announced this morning that it has newly created the role of President at the firm,
Read moreTetra Bio-Pharma Inc. (TSXV: TBP) has entered into a manufacturing agreement with Vitiprints LLC, which will enable the company to
Read moreTetra Bio-Pharma (TSXV: TBP) has received a much anticipated response from the US Food and Drug Administration (FDA) regarding the
Read moreTetra Bio-Pharma Inc (TSXV: TBP) has released an update regarding its clinical study for the veterinary treatment of eye pain
Read moreTetra Bio Pharma (TSXV: TBP) this morning announced that it will be conducting a financing for up to $10 million
Read moreTetra Bio Pharma (TSXV: TBP) released information on its commercialization effort this morning related to two products that received Health
Read more